Form D/A — EnZeta Immunotherapies, Inc.
0001994145-26-000001 · filed Mar 6, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $2,370,000
- Reported amount sold
- $840,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- EnZeta Immunotherapies, Inc.
- CIK
- 1994145
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 122 SEVILLA AVE # 919
CORAL GABLES, Florida 33134 - Phone
- 9173644613
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Paul Kelly · Executive OfficerCoral Gables, Florida Find on LinkedIn ↗
-
Sergio Traversa · DirectorMiami, Florida Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗